AUSTAR Connecting Extraordinary Ideas

/ Consulting & Digitalization and Construction / Case Study

BSL2 & 3 Veterinary Vaccine Facilities

The veterinary vaccine market in the MENA region has reached a value of several hundred million US dollars currently. With the increasing focus on animal health, the market potential for veterinary vaccines is expected to be even greater in the next 3-5 years. Additionally, with the continuous advancement of technology and the increasingly stringent regulatory requirements, the technical barriers and compliance standards in the veterinary vaccine industry will be further raised. The client owns several product pipelines and has successfully entered markets in over 40 countries worldwide, with business operations spanning from Asia to Africa. They are currently planning to expand into the European market. - Product：Veterinary vaccine - Project Standards：WHO、EU GMP - Facility type:：Greenfield、7DS lines、3DP lines - Project area：10000+ m2 - Project-Driven：BSL2/3、 Compliance、High-Efficiency Facilities

AUSTAR Solution

Service Scope： FEE&C - Project management - Process engineering design - CU & CIP engineering design - Production Facility Engineering Design - R&D, QC, Warehouse Engineering Design - Detailed design

Project Challenges： - Risk assessment for multiple product lines to avoid cross-contamination - Designing isolation between toxic and non-toxic areas - Biosafety v.s. GMP - Compliance with local regulations for construction, electrical, and automation system - Equipment and systems selection to balance local regulations and supply chain considerations

AUSTAR Value & Client Benefits

• Technical Solutions for biosafety facilities • Deep Understanding of International GMP Standards and Biosafety • CAPEX v.s. OPEX, cost control • Integrated Capability from Engineering Design, Construction to System Validation

Go Back Read More